Gloshell
Ingredients

Ingredient Dictionary

DIMETHYL-3-METHYLPENTADIENYL-OXIRANE

Molecular structure

Definition

US FDA substance register · UNII GI3799S29T · registered name .BETA.-OCIMENE EPOXIDE · mixture

Source: US FDA Unique Ingredient Identifier (UNII)

Cosmetic roles

Gives the product a scentPERFUMING

Safety & regulatory references

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

More data — names, identifiers, properties, test records, literature

Names & identifiers

DIMETHYL-3-METHYLPENTADIENYL-OXIRANEINCIOxirane, 2,2-dimethyl-3-(3-methyl-2,4-pentadienyl)-Synonym
CAS No.chemical registry number
69103-20-4
EC No.EU chemical inventory number
273-870-4
DTXSIDUS EPA chemical ID
DTXSID3052436
DTXCIDUS EPA compound ID
DTXCID5031008
IUPAC
2,2-Dimethyl-3-(3-methylpenta-2,4-dien-1-yl)oxirane
Molecular formula
C10H16O
Molecular weight
152.237 g/mol

Measured properties

Appearance
liquid
Melting/freezing point
-20 ± 0.5 ℃
Initial boiling point and range
198.34 ℃
Flash point
73 ± 2 ℃
Vapour pressure
46 ㎩ (25℃)
Relative density
0.881 (20 ± 0.5°)
n-Octanol/water partition coefficient (Kow)
?log Pow = 2.99 (30℃)
Auto-ignition temperature
265 ℃ (1005.2)
Molecular weight
152.235

Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.

Source: KOSHA safety data sheets (Korea)

What products actually use it for

What the 10 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Fragrance10

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

2 skin studies and 1 eye studies are on record.

Classed as highly irritating1Classed as low1

The studies disagree (the most common conclusion covers 50%), so they do not establish that this ingredient is irritating. These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 3 studies
  • High Frequency of Sensitization
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) according to EPA OPPTS 870.2600 (Skin Sensitisation)
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.42 according to

Source: US EPA CompTox dashboard

Linked databases 10